Showing results (431-440 of 976) with videos related to

Sort By:
Pageof 98
NPJ Breast Cancer|December 4, 2025
Night shift work and breast cancer: from etiopathology to precision risk analysisSilvia Vivarelli, Tania Formica, Ylenia Puliatti, et al.
NPJ Breast Cancer|December 2, 2025
HER2-low breast cancer is immune-cold: insights into tumor-infiltrating immune cells and implications for immunotherapyS Pizzamiglio, A Blanda, V Appierto, et al.
NPJ Breast Cancer|December 20, 2024
The EstroGene2.0 database for endocrine therapy response and resistance in breast cancerZheqi Li, Fangyuan Chen, Li Chen, et al.
NPJ Breast Cancer|January 14, 2025
Co-targeting of metabolism using dietary and pharmacologic approaches reduces breast cancer metastatic burdenQianying Zuo, Jin Young Yoo, Erik R Nelson, et al.
NPJ Breast Cancer|January 6, 2024
Molecular imaging predicts lack of T-DM1 response in advanced HER2-positive breast cancer (final results of ZEPHIR trial)Magdalena Mileva, Elisabeth G E de Vries, Thomas Guiot, et al.
NPJ Breast Cancer|January 3, 2024
cGAS-STING pathway expression correlates with genomic instability and immune cell infiltration in breast cancerMengting Chen, Shibo Yu, Tineke van der Sluis, et al.
NPJ Breast Cancer|January 20, 2024
A polygenic score associated with fracture risk in breast cancer patients treated with aromatase inhibitorsChristine Hook, Udit Chatterjee, Haiyang Sheng, et al.
NPJ Breast Cancer|September 30, 2024
Pharmacokinetics and pharmacogenomics of ribociclib in black patients with metastatic breast cancer the LEANORA studyIlana Schlam, D Max Smith, Cody Peer, et al.
NPJ Breast Cancer|October 2, 2024
Prognostic and therapeutic implications of tumor-restrictive type III collagen in the breast cancer microenvironmentDaniel C Stewart, Becky K Brisson, Bassil Dekky, et al.
NPJ Breast Cancer|September 14, 2024
Mcam stabilizes a luminal progenitor-like breast cancer cell state via Ck2 control and Src/Akt/Stat3 attenuationOzlen Balcioglu, Brooke L Gates, David W Freeman, et al.
Pageof 98